-+ 0.00%
-+ 0.00%
-+ 0.00%

Genmab posts Q3 2026 DARZALEX net sales of USD 4.24 billion, J&J data show

PUBT·10/13/2026 11:50:49
Listen to the news
Genmab posts Q3 2026 DARZALEX net sales of USD 4.24 billion, J&J data show
  • Genmab reported worldwide net trade sales of DARZALEX at USD 4.24 billion in Q3 2026, based on figures reported by J&J.
  • U.S. net trade sales reached USD 2.53 billion during the quarter; rest-of-world sales totaled USD 1.71 billion.
  • Genmab earns royalties on worldwide DARZALEX net sales under its exclusive global license to J&J, covering IV and SC forms.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001434265-26-000136), on October 13, 2026, and is solely responsible for the information contained therein.